Header Logo

Connection

ROBERT A WOLFF to Radiotherapy, Adjuvant

Back to Details
This is a "connection" page, showing publications ROBERT A WOLFF has written about Radiotherapy, Adjuvant.
ROBERT A WOLFF
Connection Strength
0.962
Radiotherapy, Adjuvant
  1. Adjuvant therapy for pancreatic cancer: a logical strategy in search of progress. Ann Surg Oncol. 2011 May; 18(5):1224-8.
    View in: PubMed
    Score: 0.267
  2. Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: correlation of Smad4(Dpc4) immunostaining with pattern of disease progression. J Clin Oncol. 2011 Aug 01; 29(22):3037-43.
    View in: PubMed
    Score: 0.067
  3. Is there a role for adjuvant therapy in resected adenocarcinoma of the small intestine. Acta Oncol. 2010 May; 49(4):474-9.
    View in: PubMed
    Score: 0.062
  4. Challenges in the study of adjuvant chemoradiation after pancreaticoduodenectomy. Ann Surg Oncol. 2010 Apr; 17(4):950-2.
    View in: PubMed
    Score: 0.062
  5. Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head. J Clin Oncol. 2008 Jul 20; 26(21):3496-502.
    View in: PubMed
    Score: 0.055
  6. Adjuvant therapy for adenocarcinoma of the pancreas: analysis of reported trials and recommendations for future progress. Ann Surg Oncol. 2008 Oct; 15(10):2773-86.
    View in: PubMed
    Score: 0.055
  7. Pancreatic adenocarcinoma. Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2007 Nov; 5(10):998-1033.
    View in: PubMed
    Score: 0.052
  8. Future chemoradiation strategies in pancreatic cancer. Semin Oncol. 2007 Aug; 34(4):335-46.
    View in: PubMed
    Score: 0.051
  9. Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer. J Clin Oncol. 2006 Mar 01; 24(7):1145-51.
    View in: PubMed
    Score: 0.047
  10. Neoadjuvant therapy for resectable pancreatic cancer. Surg Oncol Clin N Am. 2004 Oct; 13(4):639-61, ix.
    View in: PubMed
    Score: 0.042
  11. The cost-effectiveness of neoadjuvant chemoradiation is superior to a surgery-first approach in the treatment of pancreatic head adenocarcinoma. Ann Surg Oncol. 2013 Dec; 20 Suppl 3:S500-8.
    View in: PubMed
    Score: 0.019
  12. Yield of clinical and radiographic surveillance in patients with resected pancreatic adenocarcinoma following multimodal therapy. HPB (Oxford). 2012 Jun; 14(6):365-72.
    View in: PubMed
    Score: 0.018
  13. Survival and quality of life of patients with resected pancreatic adenocarcinoma treated with adjuvant interferon-based chemoradiation: a phase II trial. Ann Surg Oncol. 2011 Dec; 18(13):3615-22.
    View in: PubMed
    Score: 0.017
  14. Serum CA 19-9 as a marker of resectability and survival in patients with potentially resectable pancreatic cancer treated with neoadjuvant chemoradiation. Ann Surg Oncol. 2010 Jul; 17(7):1794-801.
    View in: PubMed
    Score: 0.015
  15. Phase II study of bevacizumab with concurrent capecitabine and radiation followed by maintenance gemcitabine and bevacizumab for locally advanced pancreatic cancer: Radiation Therapy Oncology Group RTOG 0411. J Clin Oncol. 2009 Sep 01; 27(25):4096-102.
    View in: PubMed
    Score: 0.015
  16. Combined modality treatment of resectable and borderline resectable pancreas cancer: expert consensus statement. Ann Surg Oncol. 2009 Jul; 16(7):1751-6.
    View in: PubMed
    Score: 0.014
  17. Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma. Ann Surg Oncol. 2009 Apr; 16(4):836-47.
    View in: PubMed
    Score: 0.014
  18. Role of adjuvant chemoradiation therapy in adenocarcinomas of the ampulla of vater. Int J Radiat Oncol Biol Phys. 2008 Mar 01; 70(3):735-43.
    View in: PubMed
    Score: 0.013
  19. Delayed recovery after pancreaticoduodenectomy: a major factor impairing the delivery of adjuvant therapy? J Am Coll Surg. 2007 Mar; 204(3):347-55.
    View in: PubMed
    Score: 0.012
  20. Pancreatic adenocarcinoma: Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2005 Sep; 3(5):598-626.
    View in: PubMed
    Score: 0.011
  21. Localized adenocarcinoma of the pancreas: the rationale for preoperative chemoradiation. Oncologist. 2002; 7(1):34-45.
    View in: PubMed
    Score: 0.009
  22. Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration. Ann Surg Oncol. 2001 Mar; 8(2):123-32.
    View in: PubMed
    Score: 0.008
  23. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region. Ann Surg. 2000 Nov; 232(5):727.
    View in: PubMed
    Score: 0.008
  24. Preoperative chemoradiation for patients with locally advanced adenocarcinoma of the pancreas. Ann Surg Oncol. 1999 Jan-Feb; 6(1):38-45.
    View in: PubMed
    Score: 0.007
  25. Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma. J Clin Oncol. 1998 Dec; 16(12):3843-50.
    View in: PubMed
    Score: 0.007
  26. Neoadjuvant chemoradiation for adenocarcinoma of the pancreas. Front Biosci. 1998 Nov 01; 3:E193-203.
    View in: PubMed
    Score: 0.007
  27. Preoperative chemoradiation strategies for localized adenocarcinoma of the pancreas. J Hepatobiliary Pancreat Surg. 1998; 5(3):242-50.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.